Table 1.
Clinicopathological parameters of patients, with respectively good and bad outcome
| Category | Gender | Age | Location | pG | pT | pN | pM | pR | PNI | LVI | VI | Postop | OS | DFS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GOOD |
F |
55 |
Head |
2 |
2 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
156.4 |
156.4 |
| GOOD |
M |
32 |
Head |
3 |
3 |
1 |
0 |
0 |
1 |
1 |
0 |
RCT |
127.9 |
127.9 |
| GOOD |
M |
78 |
Head |
1 |
3 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
71.5 |
71.5 |
| GOOD |
M |
53 |
Head |
3 |
3 |
1 |
0 |
0 |
1 |
0 |
1 |
RCT |
67.2 |
67.2 |
| GOOD |
F |
61 |
Head |
3 |
3 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
56.4 |
56.4 |
| GOOD |
F |
62 |
Head |
3 |
3 |
1 |
0 |
0 |
0 |
0 |
1 |
RCT |
62.7 |
62.7 |
| GOOD |
M |
68 |
Tail |
3 |
2 |
0 |
0 |
0 |
1 |
0 |
1 |
CT |
51.5 |
51.5 |
| BAD |
F |
75 |
Head |
3 |
3 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
9.4 |
5.2 |
| BAD |
M |
72 |
Head |
2 |
3 |
1 |
0 |
0 |
1 |
1 |
1 |
CT |
12.6 |
5.6 |
| BAD |
M |
52 |
Head |
3 |
3 |
0 |
0 |
0 |
1 |
0 |
1 |
0 |
8.4 |
4.1 |
| BAD |
F |
78 |
Head |
2 |
3 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
9.9 |
3.6 |
| BAD |
M |
59 |
Head |
3 |
3 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
6.3 |
2.8 |
| BAD |
F |
51 |
Head |
3 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
CT |
19.4 |
6.5 |
| BAD |
M |
74 |
Tail |
3 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
CT |
12.3 |
0.5 |
| BAD |
M |
50 |
Head |
2 |
2 |
1 |
0 |
0 |
1 |
1 |
1 |
CT |
9.4 |
7.0 |
| BAD(M) | M | 67 | Head | 1 | CT | 8.3 | / |
F: female; M: male; pG: pathological tumour grade; pT: pathological tumour size; pN: pathological lymph node status; pM: pathological metastasis; pR: pathological resection margin; PNI: perineural invasion; VI: vascular invasion; LVI: lymphovascular invasion; RCT: radiochemotherapy; CT: chemotherapy; OS: overall survival; DFS: disease-free survival.